Moderna’s newly approved vaccine could allow manufacturers to respond more rapidly to changing influenza strains.

The approval of the vaccine, called mFLUSIVA, which is manufactured by Moderna, follows a series of blows to mRNA research ...

Previously, the COVID-19 immunizations made by Pfizer and Moderna were the only mRNA vaccines on the market.

This flu shot, mFlusiva, was shown in a clinical trial to be up to 27 percent more effective than a standard flu jab ...

Fact checked by Elizabeth Gall Key takeaways The FDA approved mFLUSIVA, the first mRNA flu vaccine, for adults 50 and ...

The Food and Drug Administration just approved the new type of flu vaccine for adults ages 50 and older. It relies on the ...

The Food and Drug Administration this week approved the first mRNA flu vaccine for adults 50 and older. Health experts lauded ...

For the first time, the United States has an mRNA flu shot. The FDA has cleared Moderna’s mFlusiva for adults aged 50 and ...

The Food and Drug Administration is expected to decide whether to approve the first mRNA flu vaccine.

What Is mFlusiva, and How Does It Work? The FDA approved mFlusiva to help prevent the flu in adults ages 50 and older. The flu is a viral infection that affects the lungs and breathing airways. It ...

Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 ...

The U.S. Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is ...